Jamaica is attempting to make itself as synonymous with medical-grade psychedelics in the minds of researchers as it is with cannabis production in the minds of many
Industry associations hope a review of UK policy on cannabinoids will help the government address regulation that has limited the development of the CBD and wider sectors
This regulatory report analyses the different approaches taken by states over what restrictions they impose on medical cannabis products that patients can buy
This report offers a comprehensive overview of the current regulatory framework for hemp, CBD and cannabis (medical and recreational) as well as possible upcoming changes
A Polish appeals court has put forward a decision that may be out of kilter with many other interpretations of the status of hemp as a novel food
This report aims to analyse the developments of the European CBD regulatory landscape almost one and a half years after the crucial ruling of the Kanavape case
This report offers a detailed overview of the current regulatory regime in place in Ireland for CBD, hemp and cannabis
Canada’s cannabis trade is celebrating after the government tabled a budget calling for steps to streamline a variety of tax measures and launch a strategy group to examine ways to grow the industry
Five years after German patients were first allowed to obtain medical cannabis, demand has risen sharply – but there are still some unanswered issues on policy and practice that lobbyists want addressed
The Cabinet of the Moroccan government has formally adopted the decision to authorise three regionsto lawfully grow cannabis solely for medical purposes
Argentina’s president is urging the national Congress to approve a law this year that would establish a legal framework for the production and sale of medicinal cannabis and industrial hemp
The Canadian government is proposing changes to make it easier to conduct non-therapeutic cannabis research in the country and to foster more investigation into the development of cannabis products
A two-tier THC limit providing more leniency for the production of flowers is the latest addition to Colombia’s strong cannabinoid regulatory foundations
CBD stakeholders hoping for clarity in US regulations were left disappointed by the passing of the $1.5tn omnibus spending bill earlier this month as some helpful language was dropped during the final negotiations
This report covers the regulatory framework for CBD, hemp and cannabis in Brazil
Regulatory changes in Israel have enabled a cannabis company to advance breeding methods and grow plants that promise to yield higher levels of cannabinoids